Challenges of peptide and protein drug delivery by oral route: Current strategies to improve the bioavailability

Abstract

Advancement in biotechnology provided a notable expansion of peptide and protein therapeutics, used as antigens, vaccines, hormones. It has a prodigious potential to treat a broad spectrum of diseases such as cancer, metabolic disorders, bone disorders, and so forth. Protein and peptide therapeutics are administered parenterally due to their poor bioavailability and stability, restricting their use. Hence, research focuses on the oral delivery of peptides and proteins for the ease of self‐administration. In the present review, we first address the main obstacles in the oral delivery system in addition to approaches used to enhance the stability and bioavailability of peptide/protein. We describe the physiochemical parameters of the peptides and proteins influencing bioavailability in the systemic circulation. It encounters, many barriers affecting its stability, such as poor cellular membrane permeability at the GIT site, enzymatic degradation (various proteases), and first‐pass hepatic metabolism. Then describe the current approaches to overcome the challenges mentioned above by the use of absorption enhancers or carriers, structural modification, formulation and advance technology.

Fungal Proteases as Emerging Biocatalysts to Meet the Current Challenges and Recent Developments in Biomedical Therapies: An Updated Review

“…Some significant challenges are addressed by the protease group in the development and usage of technologies at GNF in understanding protease biology to develop protease-based targeted therapeutics [255]. The GNF protease platform enables the use of comprehensive technologies that help identify native and optimal substrates [256]. Due to industrial development, environmental pollution has become a major concern, and chemically thermostable protease has taken over the conventional protease [257].…”

The Emerging Role of Ionic Liquid-Based Approaches for Enhanced Skin Permeation of Bioactive Molecules: A Snapshot of the Past Couple of Years

“…Proteins and peptides are, by far, the most widely and deeply studied biomacromolecules, given their multiple pharmaceutical and biomedical applications, stemming from their broad range of structural, physicochemical, and biological properties, associated to a high level of specificity, thus representing the majority of biopharmaceuticals approved for therapeutic use [ 162 ]. Yet, most protein and peptides pose many challenges for therapeutic applications, mostly related to their low bioavailability and in vivo stability, which underpins intensive research on strategies for efficient protein and peptide delivery specifically aimed at oral and topical administration routes [ 158 , 163 ]. IL-mediated delivery of proteins has been investigated in recent years, with emphasis on insulin, since topical administration of this protein is highly convenient to promote higher comfort and compliance in diabetic patients.…”

Approaches to minimize the effects of P‐glycoprotein in drug transport: A review

“…In the intestine, P‐gp effluxes the drug and limits its oral bioavailability, reducing its in‐vivo efficacy (AboulFotouh et al, 2018; Verma et al, 2021). The mechanism of drug efflux by P‐gp is poorly understood.…”